Dr. Amer Zeidan from Yale School of Medicine explains the uses, benefits, and risks of the newly approved treatment, Inqovi.

AAMDSIF Podcasts for Patients

AAMDSIF Podcast for Patients: MDS - Inqovi Treatment with Dr. Amer Zeidan

Dr. Eunice Wang explains the origin and treatment of secondary MDS. Dr. Wang is the Chief of the Leukemia Service at Roswell Park Comprehensive Center.

AAMDSIF Podcast Episode 49: Dr. Eunice Wang discusses Secondary MDS

Dr. David Steensma discusses MDS and toxins with Leigh Clark, Patient Educator. Dr. Steensma is an associate professor at Harvard Medical School and faculty member in the leukemia program at the Dana-Farber Cancer Institute and Brigham and Women's Hospital in Boston, Massachusetts and the Edward P. Evans Chair in MDS at Dana-Farber Cancer Institute

AAMDSIF SERIES Podcast Episode 48: Dr David Steensma discusses MDS and toxins

Dr. Abdulraheem Yacoub talks with Leigh Clark about MDS-MPNs overlap. He includes how molecular testing is used in determining treatment options. He also discusses the newly approved drug, Luspatercept, for the treatment of MDS and MDS-MPN overlap syndromes.

AAMDSIF Podcast Episode 47: Dr. Yacoub explains MDS-MPNs overlap

During COVID-19, the PAN Foundation is giving grants to certain AML and CML patients. Listen to this broadcast to learn the details.

AAMDSIF Podcast Episode 45: PAN Foundation's grants for patients

Discussion of the recent approval of Luspatercept with Doctor Amit Verma, Director of the Division of Hematologic Malignancies and a Professor of Oncology at the Albert Einstein College of Medicine in New York City. #MDS #treatingMDS

AAMDSIF Podcast for Patients Episode 46: Luspatercept with Dr. Amit Verma

Dr. Gustavo Rivero describes strategies for management of Low-Risk MDS, or Myelodysplastic Syndromes. He details supportive care for these patients, including transfusions and iron overload therapies.

AAMDSIF Podcast for Patients Episode 44: Dr. Gustavo Rivero on Low-Risk MDS and Supportive Care

Dr Vu Duong explains risk classifications for MDS. He dives into IPSS and IPSS-R scores, focused on helping patients to understand the meanings of high-risk and low-risk MDS.

AAMDSIF Podcast Episode 43: Dr. Vu Duong

Julie Lowe, AAMDSIF Director for Strategic Initiatives, anticipates your questions about getting involved with the Aplastic Anemia and MDS International Foundation in this recent interview.

AAMDSIF Podcast Episode 42: Julie Lowe explains March for Marrow and other events

Dr. Tiffany Tanaka from the University of California, San Diego explains the development of High-Risk MDS into AML. She talks about new diagnostic and treatment regimens for these patients.

AAMDSIF Podcast Episode 41: MDS to AML, treatment and options with Dr. Tiffany Tanaka, UC San Diego

MDS: Eliot shares his journey of diagnosis, treatment, transplant, and clinical trial for MDS with IDH1 and IDH2 mutations and AML. Myelodysplastic Syndromes, Acute Myeloid Leukemia, bone marrow transplant

AAMDSIF Podcast Episode 40: Eliot thrives after transplant and clinical trial for MDS - AML

Dr. Ehab Atallah describes advances in bone marrow transplant to treat MDS, Myelodysplastic Syndromes, in older patients.

AAMDSIF Episode 39

Thomas was too young for MDS, typically. His mom, Terri, describes diagnosis, treatment, and survivorship for him here. #myelodysplasticSyndromes #myelodysplasia #BoneMarrowFailure

AAMDSIF Podcast Episode 38

Three generations of MDS, and Leigh Ann is stuck in the middle! Discover not only how she and her son are surviving, but also how far clinical research has advanced since her mother's disease here.

AAMDSIF Podcast Episode 37

Leticia stays active and happy after conquered aplastic anemia was followed by MDS, or Myelodysplastic Syndromes. Discover how she does it here!

AAMDSIF Podcast Episode 36

"Podcasts for Patients" from the Aplastic Anemia and MDS International Foundation. For more, see our podcast page at: https://www.aamds.org/podcast/

hubhopper

AAMDSIF Podcasts for Patients

hubhopper